Come up with a name for your new list and we'll add to it:
Pearl Therapeutics was acquired by
AstraZeneca on June 10, 2013.
Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. …